Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 17, 2017 - Issue 6
Submit an article Journal homepage
563
Views
15
CrossRef citations to date
0
Altmetric
Drug Evaluation

Sirukumab: a promising therapy for rheumatoid arthritis

Eleftherios PelechasRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, GreeceView further author information
,
Paraskevi V. VoulgariRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, GreeceView further author information
&
Alexandros A. DrososRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, GreeceCorrespondence[email protected]
View further author information
Pages 755-763 | Received 09 Dec 2016, Accepted 30 Mar 2017, Published online: 10 Apr 2017

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Eleftherios Pelechas, Paraskevi V Voulgari & Alexandros A Drosos. (2019) Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis. Therapeutics and Clinical Risk Management 15, pages 1073-1079.
Read now
Eleftherios Pelechas, Paraskevi V. Voulgari & Alexandros A. Drosos. (2018) ABP 501 for the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 18:3, pages 317-322.
Read now

Articles from other publishers (13)

Menglin Zhu, Qian Ding, Zhongxiao Lin, Rong Fu, Fuyuan Zhang, Zhaoyi Li, Mei Zhang & Yizhun Zhu. (2023) New Targets and Strategies for Rheumatoid Arthritis: From Signal Transduction to Epigenetic Aspect. Biomolecules 13:5, pages 766.
Crossref
Eugen Feist & Evgeny Nasonov. (2023) Interleukin 6 Inhibition in Rheumatoid Arthritis: Highlight on Olokizumab. Rheumatology 2:1, pages 17.
Crossref
E. L. Nasonov & Eugen Feist. (2022) The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6). Rheumatology Science and Practice 60:5, pages 505-518.
Crossref
Mark David Tricklebank, Trevor W. Robbins, Camilla Simmons & Erik H. F. Wong. (2021) Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology. Psychopharmacology 238:6, pages 1417-1436.
Crossref
Ning Tang, Yulei Dong, Chong Chen & Hong Zhao. (2020) Anisodamine Maintains the Stability of Intervertebral Disc Tissue by Inhibiting the Senescence of Nucleus Pulposus Cells and Degradation of Extracellular Matrix via Interleukin-6/Janus Kinases/Signal Transducer and Activator of Transcription 3 Pathway. Frontiers in Pharmacology 11.
Crossref
Bergithe E. Oftedal & Anette S. B. Wolff. (2020) New era of therapy for endocrine autoimmune disorders. Scandinavian Journal of Immunology 92:5.
Crossref
Pelechas Eleftherios & Karagianni Panagiota. (2020) Rheumatoid arthritis: Treatment evolution over the years. Open Journal of Pharmacology and Pharmacotherapeutics 5:1, pages 024-026.
Crossref
Kathryn A. Wierenga, Jack R. Harkema & James J. Pestka. (2019) Lupus, Silica, and Dietary Omega-3 Fatty Acid Interventions. Toxicologic Pathology 47:8, pages 1004-1011.
Crossref
Tsutomu Takeuchi, Hisashi Yamanaka, Masayoshi Harigai, Ryo Tamamura, Yuichi Kato, Yoshifumi Ukyo, Toshikazu Nakano, Benjamin Hsu & Yoshiya Tanaka. (2018) Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients. Arthritis Research & Therapy 20:1.
Crossref
Yan Xu, Chuanpu Hu, Yanli Zhuang, Benjamin Hsu, Zhenhua Xu, Amarnath Sharma & Honghui Zhou. (2018) Exposure-Response Modeling Analyses for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin 6, in Patients With Moderately to Severely Active Rheumatoid Arthritis. The Journal of Clinical Pharmacology 58:11, pages 1501-1515.
Crossref
Yan Xu, Chuanpu Hu, Yanli Zhuang, Benjamin Hsu, Zhenhua Xu & Honghui Zhou. (2018) Confirmatory Population Pharmacokinetic Analysis for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin-6, in Patients With Moderately to Severely Active Rheumatoid Arthritis. The Journal of Clinical Pharmacology 58:7, pages 939-951.
Crossref
Raimon Sanmartí, Virginia Ruiz-Esquide, Carla Bastida & Dolor Soy. (2018) Tocilizumab in the treatment of adult rheumatoid arthritis. Immunotherapy 10:6, pages 447-464.
Crossref
VP Priyatama. (2018) Moringa Oleifera: Panaromic View on Nutritional, Therapeutic Activity and Patent Landscape. International Journal of Pharmaceutical Sciences and Developmental Research 3:1, pages 024-028.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.